Asprota
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- HHSO100201300011C
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Other Transaction Agreement - New antibacterials for hospital and biothreat pathogens: a portfolio paradigm Award Notice · Posted May 22, 2013
- Last date to order 82% complete
- IDV ceiling
- $218,529,832.87
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 30 offers Negotiated Proposal / Quote
- Pricing
- Cost Sharing
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract, awarded to GlaxoSmithKline, LLC on May 20, 2013, by the Office of the Assistant Secretary for Preparedness and Response (ASPR), supports the development and delivery of new antibacterial agents targeting hospital-acquired pathogens and biothreat organisms under the "New Antibacterials for Hospital and Biothreat Pathogens: A Portfolio Paradigm" (ASPROTA) program. The contract carries a ceiling value of $218.5 million and extends through September 30, 2029, providing a single-award vehicle with no set-aside designation. As a civilian federal contract, this IDV reflects the government's strategic investment in pharmaceutical countermeasures and antimicrobial innovation to address critical public health threats, including nosocomial infections and potential biodefense requirements.
GlaxoSmithKline's contract performance under this IDV contributes to the Department of Health and Human Services' broader preparedness and response mission by advancing the pharmaceutical company's antimicrobial development capabilities. The contractor's established federal contracting history with multiple agencies—including the Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Defense—demonstrates its capacity to deliver complex pharmaceutical products and medical countermeasures at scale. Recent contract modifications have included updates to program governance structure, such as the replacement of Joint Oversight Committee members, reflecting ongoing program management and administrative adjustments throughout the contract period. This indefinite delivery vehicle enables flexible procurement of antibacterial agents and related research services as they advance through development and regulatory approval processes.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $2,678,330 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $13,800,000 | |
| Funding Only Action | -$1,612,786 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | -$363 | |
| Other Administrative Action | $15,000,000 | |
| Supplemental Agreement for work within scope | -$34,098 | |
| Supplemental Agreement for work within scope | $9,000,000 | |
| Other Administrative Action | $0 | |
| Change Order | $28,100,000 | |
| Exercise an Option | $25,000,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$144,551 | |
| Funding Only Action | $4,343,300 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $800,000 | |
| Exercise an Option | $40,000,000 | |
| Additional Work (new agreement, FAR part 6 applies) | $1,600,000 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $40,000,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $40,000,000 |
Show all 41
Quick answers
Who was awarded contract HHSO100201300011C?
HHSO100201300011C was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on May 20, 2013.
How much is contract HHSO100201300011C worth?
HHSO100201300011C's own ceiling is $218,529,833.
Who can order from contract HHSO100201300011C?
HHSO100201300011C is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HHSO100201300011C competed?
The extent of competition for HHSO100201300011C was full and open competition. The government received 30 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV